Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2017 · 10-Q
Revenue$531.00K$531.00K+185.5% vs Q1 2016 Net Income-$1.74M-$1.74MN/M vs Q1 2016 EPS Diluted-$0.03-$0.03N/M vs Q1 2016 Operating Income-$1,597,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,123,000— Margins · derivedOperating margin-300.8%+700.3 pt vs Q1 2016
Net margin-328.2%+1187.9 pt vs Q1 2016
ended Oct 31, 2016 · filed Dec 14, 2016 · 44 d after period end